Moderately bullish activity in Pfizer (PFE), with shares up 34c, or 1.29%, near $27.02. Options volume running well above average with 164k contracts traded and calls leading puts for a put/call ratio of 0.31, compared to a typical level near 0.55. Implied volatility (IV30) is higher by 0.9 points near 25.94,and above the 52wk median, suggesting an expected daily move of $0.44. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Pfizer (PFE) will report earnings before the open on 2026-05-05.Option markets are pricing in a 50% probability of a move greater than 3.11% or $0.84.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Bristol Myers-Pfizer Alliance launch collaboration with Mark Cuban for Eliquis
- Pfizer Advances PF-08653944 Liver Study, Reinforcing Long-Term Pipeline Visibility
- Pfizer’s New Phase 1 Cancer Trial Adds Quiet Optionality to PFE’s Pipeline
- Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study
- Pfizer Advances Early-Stage Heart Failure Candidate With Completion of Chinese Phase 1 Study
